{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:08:53Z","timestamp":1792591733761,"version":"4.5.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Human papillomavirus (HPV) infection serves as a primary causative agent of cervical cancer, highlighting the importance of early screening and detection in mitigating the incidence and mortality rates of HPV-related diseases. Over the past decades, HPV detection technologies have evolved considerably, transitioning from traditional methods to more advanced, patient-centered approaches. This review provides a comprehensive overview of both established and emerging HPV detection strategies, with a particular focus on their clinical applicability, technical advantages, and limitations. Conventional methods such as hybrid capture and PCR-based assays remain the backbone of clinical screening, offering robust sensitivity and specificity. However, their reliance on invasive sampling and centralized laboratory infrastructure limits accessibility and patient compliance, particularly in low-resource settings. To address these limitations, emerging technologies\u2014including CRISPR\/Cas systems, droplet digital PCR (ddPCR), next-generation sequencing (NGS), isothermal amplification techniques (IAT) and artificial intelligence (AI) combined with hpv screening offer enhanced accuracy, rapid turnaround, and the potential for point-of-care deployment. In parallel, innovations in sampling such as self-collected vaginal swabs and liquid biopsy using urine, blood, or extracellular vesicles are improving test acceptability and broadening screening coverage. By summarizing current progress and highlighting ongoing challenges, this review aims to guide the development of more precise, non-invasive, and scalable HPV detection strategies to reduce the global burden of HPV-related disease, support global prevention efforts, and guide public health policies.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1681779","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:05Z","timestamp":1762842725000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Evolving HPV diagnostics: current practice and future frontiers"],"prefix":"10.3389","volume":"15","author":[{"given":"Lin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jclinpath-2021-208054","article-title":"Agreement between L1 and E6\/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers","volume":"76","author":"Alcaniz Boada","year":"2023","journal-title":"J. Clin. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/cancers14030652","article-title":"Targeted next generation sequencing for human papillomavirus genotyping in cervical liquid-based cytology samples","volume":"14","author":"Andersen","year":"2022","journal-title":"Cancers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.21873\/anticanres.11807","article-title":"Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test","volume":"37","author":"Asciutto","year":"2017","journal-title":"Anticancer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/ijc.34170","article-title":"Human papillomavirus self-sampling with mRNA testing benefits routine screening","volume":"151","author":"Auvinen","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"122118","DOI":"10.1016\/j.talanta.2021.122118","article-title":"Flexible sensor based on conducting polymer and gold nanoparticles for electrochemical screening of HPV families in cervical specimens","volume":"226","author":"Avelino","year":"2021","journal-title":"Talanta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12885-022-09262-4","article-title":"Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA","volume":"22","author":"Bhat","year":"2022","journal-title":"BMC Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1128\/JCM.02716-14","article-title":"Clinical validation of the cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening","volume":"52","author":"Boers","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e01518","DOI":"10.1128\/JCM.01518-19","article-title":"Clinical and analytical performance of the BD onclarity HPV assay with surePath screening samples from the danish cervical screening program using the VALGENT framework","volume":"58","author":"Bonde","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00013-15","article-title":"Human papillomavirus laboratory testing: the changing paradigm","volume":"29","author":"Burd","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tig.2015.06.001","article-title":"Accessing genetic information with liquid biopsies","volume":"31","author":"Cai","year":"2015","journal-title":"Trends Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with hybrid capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40364-024-00701-x","article-title":"State of the art CRISPR-based strategies for cancer diagnostics and treatment","volume":"12","author":"Di Carlo","year":"2024","journal-title":"biomark. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.lanwpc.2025.101480","article-title":"Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study","volume":"55","author":"Dong","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jinf.2015.05.001","article-title":"Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics","volume":"71","author":"Ducancelle","year":"2015","journal-title":"J. Infect."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pvr.2016.01.003","article-title":"Clinical and analytical performance of the BD Onclarity\u2122 HPV assay for detection of CIN2+ lesions on SurePath samples","volume":"2","author":"Ejegod","year":"2016","journal-title":"Papillomavirus. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s10020-025-01238-x","article-title":"Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay","volume":"31","author":"Faillace Thiesen","year":"2025","journal-title":"Mol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/pathogens13080653","article-title":"Isothermal technologies for HPV detection: current trends and future perspectives","volume":"13","author":"Flores-Contreras","year":"2024","journal-title":"Pathogens"},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1021\/acssynbio.3c00655","article-title":"CRISPR-based multiplex detection of human papillomaviruses for one-pot point-of-care diagnostics","volume":"13","author":"Ghouneimy","year":"2024","journal-title":"ACS Synth. Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acssynbio.2c00496","article-title":"CRISPR-based diagnostics: challenges and potential solutions toward point-of-care applications","volume":"12","author":"Ghouneimy","year":"2022","journal-title":"ACS Synth. Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ijc.34120","article-title":"Performance of HPV E6\/E7 mRNA assay as primary screening test: Results from the NTCC2 trial","volume":"151","author":"Giorgi Rossi","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"O406","DOI":"10.1111\/1469-0691.12420","article-title":"Phylogenetically related, clinically different: human papillomaviruses 6 and 11 variants distribution in genital warts and in laryngeal papillomatosis","volume":"20","author":"God\u00ednez","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/bjc.2017.485","article-title":"Randomised study shows that repeated self-sampling and HPV test has more than twofold higher detection rate of women with CIN2+histology than Pap smear cytology","volume":"118","author":"Gustavsson","year":"2018","journal-title":"Br. J. Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/bjc.2014.510","article-title":"Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial","volume":"111","author":"Haguenoer","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/jco.23.00954","article-title":"Clinical validation of human papilloma virus circulating tumor DNA for early detection of residual disease after chemoradiation in cervical cancer","volume":"42","author":"Han","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000355952","article-title":"Human papillomavirus genomics: past, present and future","volume":"45","author":"Harari","year":"2014","journal-title":"Curr. Probl. Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"0114","DOI":"10.34133\/bmef.0114","article-title":"Application of CRISPR-cas system in human papillomavirus detection using biosensor devices and point-of-care technologies","volume":"6","author":"He","year":"2025","journal-title":"BME. Front."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2016.05.004","article-title":"Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework","volume":"81","author":"Heard","year":"2016","journal-title":"J. Clin. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/gm477","article-title":"Circulating tumor cells and DNA as liquid biopsies","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1128\/JCM.01743-09","article-title":"Comparison of the clinical performance of papilloCheck human papillomavirus detection with that of the GP5+\/6+-PCR-enzyme immunoassay in population-based cervical screening","volume":"48","author":"Hesselink","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the RNA-based aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2 HPV test in a routine screening population of women aged 30 to 60 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"339145","DOI":"10.1016\/j.aca.2021.339145","article-title":"Electrochemical bioassay coupled to LAMP reaction for determination of high-risk HPV infection in crude lysates","volume":"1187","author":"Izadi","year":"2021","journal-title":"Analytica. Chim. Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/jmv.70008","article-title":"LAMP-based electrochemical platform for monitoring HPV genome integration at the mRNA level associated with higher risk of cervical cancer progression","volume":"96","author":"Izadi","year":"2024","journal-title":"J. Med. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v16050680","article-title":"Human papillomavirus and associated cancers: A review","volume":"16","author":"Jensen","year":"2024","journal-title":"Viruses"},{"key":"B40","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.3390\/ijms24119114","article-title":"NOVAprep-miR-cervix: new method for evaluation of cervical dysplasia severity based on analysis of six miRNAs","volume":"24","author":"Kniazeva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"101827","DOI":"10.1016\/j.tranon.2023.101827","article-title":"Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis\/prognosis of head and neck cancer","volume":"40","author":"Kumar","year":"2024","journal-title":"Transl. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1309\/AJCPCQD7B7DPVHLH","article-title":"Cervista HR and HPV 16\/18 assays vs hybrid capture 2 assay outcome comparison in women with negative cervical cytology","volume":"136","author":"Kurian","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jinf.2020.05.006","article-title":"Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France","volume":"81","author":"Lefeuvre","year":"2020","journal-title":"J. Infect."},{"key":"B46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s13402-017-0331-y","article-title":"Digital droplet PCR (ddPCR) for the detection and quantification of HPV 16, 18, 33 and 45 - a short report","volume":"40","author":"Lillsunde Larsson","year":"2017","journal-title":"Cell Oncol. (Dordr)."},{"key":"B48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s11658-024-00548-y","article-title":"A multiplex RPA-CRISPR\/Cas12a-based POCT technique and its application in human papillomavirus (HPV) typing assay","volume":"29","author":"Liu","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"114193","DOI":"10.1016\/j.jviromet.2021.114193","article-title":"Optimization of droplet digital PCR assays for the type-specific detection and quantification of five HPV genotypes, including additional data on viral loads of nine different HPV genotypes in cervical carcinomas","volume":"294","author":"Malin","year":"2021","journal-title":"J. Virol. Methods"},{"key":"B50","doi-asserted-by":"publisher","first-page":"44307","DOI":"10.1021\/acsami.7b13873","article-title":"DNA modulates the interaction of genetically engineered DNA-binding proteins and gold nanoparticles: diagnosis of high-risk HPV infection","volume":"9","author":"Mao","year":"2017","journal-title":"ACS Appl. Mater. Interfac."},{"key":"B51","doi-asserted-by":"publisher","first-page":"105805","DOI":"10.1016\/j.oraloncology.2022.105805","article-title":"Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer","volume":"128","author":"Mattox","year":"2022","journal-title":"Oral. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","author":"Meijer","year":"2009","journal-title":"J. Clin. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","volume":"49","author":"Mesher","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1155\/2007\/591826","article-title":"International standard reagents for HPV detection","volume":"23","author":"Pagliusi","year":"2007","journal-title":"Dis. Markers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/JCM.00337-12","article-title":"Comparison of the abbott realTime high-risk human papillomavirus (HPV), roche cobas HPV, and hybrid capture 2 assays to direct sequencing and genotyping of HPV DNA","volume":"50","author":"Park","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e29652","DOI":"10.1002\/jmv.29652","article-title":"HPV genotyping in clinical samples using long-read single-molecule real-time sequencing","volume":"96","author":"Pasquier","year":"2024","journal-title":"J. Med. Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jmoldx.2021.10.008","article-title":"The isothermal amplification ampFire assay for human papillomavirus (HPV) detection and genotyping in formalin-fixed, paraffin-embedded oropharyngeal cancer samples","volume":"24","author":"Paytubi","year":"2022","journal-title":"J. Mol. Diagn."},{"key":"B58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","article-title":"Cervical cancer screening: A review","volume":"330","author":"Perkins","year":"2023","journal-title":"Jama"},{"key":"B59","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1128\/JCM.00382-10","article-title":"Clinical Performance of the PreTect HPV-Proofer E6\/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer","volume":"48","author":"Ratnam","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ygyno.2014.10.014","article-title":"Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology","volume":"135","author":"Rebolj","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12885-018-4087-1","article-title":"Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification","volume":"18","author":"Rohatensky","year":"2018","journal-title":"BMC Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B66","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jmv.21719","article-title":"Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test","volume":"82","author":"Schopp","year":"2010","journal-title":"J. Med. Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1101\/2024.06.28.24309678","article-title":"Human papilloma virus circulating cell-Free DNA kinetics in cervical cancer patients undergoing definitive chemoradiation","volume":"31","author":"Seo","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1158\/1078-0432.CCR-21-3151","article-title":"Cell-free HPV DNA provides an accurate and rapid diagnosis of HPV-associated head and neck cancer","volume":"28","author":"Siravegna","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1021\/acs.analchem.2c05384","article-title":"Direct virus gene detection: A CRISPR\/dCas9-mediated surface-enhanced raman scattering strategy with enzyme-catalyzed signal amplification","volume":"95","author":"Su","year":"2023","journal-title":"Anal. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1003035","DOI":"10.1371\/journal.pmed.1003035","article-title":"Advances in cervical cancer prevention: Efficacy, effectiveness, elimination","volume":"17","author":"Sundstr\u00f6m","year":"2020","journal-title":"PloS Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cas.13449","article-title":"Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells","volume":"109","author":"Takakura","year":"2018","journal-title":"Cancer Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jmv.23434","article-title":"High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping","volume":"85","author":"Tanzi","year":"2013","journal-title":"J. Med. Virol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa242","article-title":"DeepHPV: a deep learning model to predict human papillomavirus integration sites","volume":"22","author":"Tian","year":"2021","journal-title":"Brief Bioinform."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"101760","DOI":"10.1016\/j.mcp.2021.101760","article-title":"Facile and direct detection of human papillomavirus (HPV) DNA in cells using loop-mediated isothermal amplification (LAMP)","volume":"59","author":"Vo","year":"2021","journal-title":"Mol. Cell Probes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","article-title":"Detection of human papillomavirus DNA in urine. A review of the literature","volume":"31","author":"Vorsters","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jmoldx.2019.08.004","article-title":"Acoustofluidic salivary exosome isolation A liquid biopsy compatible approach for human papillomavirus-associated oropharyngeal cancer detection","volume":"22","author":"Wang","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e70482","DOI":"10.1002\/ctm2.70482","article-title":"CRISPR-driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges","volume":"15","author":"Wang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ijc.34685","article-title":"Performance of the HPV E6\/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland","volume":"154","author":"White","year":"2024","journal-title":"Int. J. Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.864820","article-title":"Molecular detection methods in HPV-related cancers","volume":"12","author":"Williams","year":"2022","journal-title":"Front. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1128\/JCM.05400-11","article-title":"Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in preservCyt medium","volume":"50","author":"Wong","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jcv.2011.03.010","article-title":"Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population","volume":"51","author":"Wong","year":"2011","journal-title":"J. Clin. Virol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"108593","DOI":"10.1016\/j.compbiomed.2024.108593","article-title":"Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy","volume":"177","author":"Xin","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/ijms19092704","article-title":"Clinical evaluation of INNO-liPA HPV genotyping EXTRA II assay using the VALGENT framework","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0225324","DOI":"10.1128\/spectrum.02253-24","article-title":"Development and evaluation of a CRISPR\/Cas12a-based diagnostic test for rapid detection and genotyping of HR-HPV in clinical specimens","volume":"13","author":"Yin","year":"2024","journal-title":"Microbiol. Spectr"},{"key":"B86","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jmv.24206","article-title":"Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus","volume":"87","author":"Yu","year":"2015","journal-title":"J. Med. Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"115229","DOI":"10.1016\/j.bios.2023.115229","article-title":"DNA tetrahedron-based CRISPR bioassay for treble-self-amplified and multiplex HPV-DNA detection with elemental tagging","volume":"229","author":"Zhan","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"B89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13027-020-00328-1","article-title":"Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening","volume":"15","author":"Zhang","year":"2020","journal-title":"Infect. Agents Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"114940","DOI":"10.1016\/j.ab.2022.114940","article-title":"Detection of target DNA with a visual CRISPR-associated hyperbranched rolling circle amplification technique","volume":"658","author":"Zhang","year":"2022","journal-title":"Anal. Biochem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e2140644","DOI":"10.1001\/jamanetworkopen.2021.40644","article-title":"Feasibility and accuracy of menstrual blood testing for high-risk human papillomavirus detection with capture sequencing","volume":"4","author":"Zhang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s00216-018-0873-5","article-title":"Detection of target DNA with a novel Cas9\/sgRNAs-associated reverse PCR (CARP) technique","volume":"410","author":"Zhang","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1186\/s12879-023-08737-4","article-title":"A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-019-0999-x","article-title":"Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1039\/D2AY01536F","article-title":"Rapid detection of HPV16\/18 based on a CRISPR-Cas13a\/Cas12a dual-channel system","volume":"14","author":"Zheng","year":"2022","journal-title":"Anal. Methods"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1681779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:32:06Z","timestamp":1762842726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1681779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":95,"alternative-id":["10.3389\/fcimb.2025.1681779"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1681779","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1681779"}}